GW Pharmaceuticals Jumps on Report It May Be Acquisition Target

GW Pharmaceuticals Plc jumped after Reuters reported that the company had hired Morgan Stanley as an adviser after being approached by several drugmakers interested in an acquisition.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.